Retrospective cohort study of reduced susceptibility of Mycobacterium tuberculosis to bedaquiline during antituberculosis treatment and its correlation with clinical outcomes in China
Latest Information Update: 24 Jul 2020
Price :
$35 *
At a glance
- Drugs Bedaquiline (Primary)
- Indications Tuberculosis
- Focus Therapeutic Use
- 24 Jul 2020 New trial record
- 15 Jul 2020 Results published in the Clinical Infectious Diseases